Procter & Gamble (PG) Stock Forecast & Price Target $144.50 +1.10 (+0.77%) Closing price 05/22/2026 03:59 PM EasternExtended Trading$144.22 -0.29 (-0.20%) As of 05/22/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Procter & Gamble - Analysts' Recommendations and Stock Price Forecast (2026) How MarketBeat Calculates Price Target and Consensus Rating Consensus Rating Moderate BuyBased on 20 Analyst RatingsSell0Hold9Buy11 Based on 20 Wall Street analysts who have issued ratings for Procter & Gamble in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 20 analysts, 9 have given a hold rating, and 11 have given a buy rating for PG. Consensus Price Target $161.0611.46% Upside According to the 20 analysts' twelve-month price targets for Procter & Gamble, the average price target is $161.06. The highest price target for PG is $175.00, while the lowest price target for PG is $145.00. The average price target represents a forecasted upside of 11.46% from the current price of $144.50. MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Get the Latest News and Ratings for PG and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Procter & Gamble and its competitors. Sign Up View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PG Analyst Ratings Over TimeTypeCurrent Forecast5/23/25 to 5/23/261 Month Ago4/23/25 to 4/23/263 Months Ago2/22/25 to 2/22/261 Year Ago5/23/24 to 5/23/25Strong Buy0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)2 Strong Buy rating(s)Buy11 Buy rating(s)12 Buy rating(s)14 Buy rating(s)15 Buy rating(s)Hold9 Hold rating(s)10 Hold rating(s)7 Hold rating(s)7 Hold rating(s)Sell0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)Consensus Price Target$161.06$162.37$168.33$179.40Forecasted Upside11.46% Upside11.39% Upside4.71% Upside8.11% UpsideConsensus RatingModerate BuyModerate BuyModerate BuyModerate Buy PG Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History PG Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table Procter & Gamble Stock vs. The CompetitionTypeProcter & GambleConsumer Staples CompaniesBroader MarketConsensus Rating Score 2.55 2.11 2.52Consensus RatingModerate BuyHoldModerate BuyPredicted Upside11.46% Upside97.33% Upside15.03% UpsideNews Sentiment RatingPositive NewsSee Recent PG NewsPositive NewsPositive News Recent Analyst Forecasts and Stock Ratings All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Years 5 Years Time Frame Start Date End Date Most Recent from Each Brokerage All Show Export DateBrokerageAnalystActionRatingPrice TargetReport Date Upside/DownsideDetails4/27/2026 UBS Group4 of 5 starsPeter Grom3 of 5 starsBoost TargetBuy$166.00 ➝ $172.00+15.75%4/27/2026 Deutsche Bank Aktiengesellschaft2 of 5 starsSteve PowersNot RatedReiterated RatingBuy$163.00+9.40%4/27/2026 Evercore3 of 5 starsRobert Ottenstein4 of 5 starsSet Target$162.00+8.73%4/27/2026 Wells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingChris CareySubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingBoost TargetOverweight$158.00 ➝ $164.00+10.73%4/27/2026 Rothschild & Co RedburnSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Lower TargetNeutral$157.00 ➝ $155.00+4.62%4/27/2026 TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingRobert MoskowSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingBoost TargetHold$142.00 ➝ $150.00+1.25%4/24/2026 Piper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingMichael LaverySubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingBoost TargetNeutral$142.00 ➝ $145.00-2.10%4/23/2026 BNP Paribas ExaneSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Lower TargetOutperform$172.00 ➝ $165.00+14.46%4/22/2026 Morgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Lower TargetOverweight$175.00 ➝ $166.00+16.12%4/20/2026 Jefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Lower TargetBuy$179.00 ➝ $175.00+21.90% Get the Latest News and Ratings for PG and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Procter & Gamble and its competitors with MarketBeat's FREE daily newsletter. 4/17/2026 JPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingAndrea TeixeiraSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingLower TargetOverweight$165.00 ➝ $162.00+12.35%4/14/2026 Raymond James FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Lower TargetOutperform$175.00 ➝ $170.00+17.78%4/14/2026 BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLauren LiebermanSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingLower TargetEqual Weight$155.00 ➝ $146.00+1.15%4/10/2026 Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingPeter GalboSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingLower TargetBuy$171.00 ➝ $167.00+13.85%4/9/2026 Royal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Lower TargetOutperform$172.00 ➝ $167.00+15.68%4/8/2026 The Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Lower TargetNeutral$159.00 ➝ $155.00+7.86%3/27/2026 Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Reiterated RatingHold (C)3/24/2026 Erste Group BankSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating DowngradeBuy ➝ Hold1/23/2026 Dbs BankSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating UpgradeHold ➝ Buy9/17/2025 Berenberg BankSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Boost TargetHold$152.00 ➝ $154.00-4.60%4/25/2025 Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBill ChappellSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingLower TargetBuy$185.00 ➝ $180.00+12.48%4/25/2025 CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingFilippo FalorniSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingLower TargetBuy$200.00 ➝ $181.00+14.38%1/23/2025 Stifel NicolausSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingMark AstrachanSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingBoost TargetHold$161.00 ➝ $165.00+0.60%1/23/2025 DA DavidsonSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingL. WeiserSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingReiterated RatingBuy$209.00 ➝ $209.00+27.00%10/4/2024 HSBCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingA. ZamaconaSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingUpgradeStrong-Buy8/29/2024 DZ BankSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating UpgradeHold ➝ Buy$190.00+12.36%8/23/2024 Wolfe ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingGreg BadishkanianSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingUpgradeStrong-BuyAnalyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 02:36 AM ET. Should I Buy Procter & Gamble Stock? PG Pros and Cons Explained These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, May 20, 2026. Please send any questions or comments about these Procter & Gamble pros and cons to contact@marketbeat.com. Procter & Gamble Bull Case Here are some ways that investors could benefit from investing in Procter & Gamble: The current stock price is around $142, which may present a buying opportunity for investors looking for value in a well-established company. Procter & Gamble has received multiple "buy" ratings from analysts, indicating strong confidence in the company's future performance. The company has a solid market capitalization of over $330 billion, reflecting its stability and prominence in the consumer goods sector. Recent insider transactions show that executives are actively managing their positions, which can signal confidence in the company's prospects. Procter & Gamble has a consistent history of dividend payments, making it an attractive option for income-focused investors. Procter & Gamble Bear Case Investors should be bearish about investing in Procter & Gamble for these reasons: Recent price target reductions by analysts, such as JPMorgan Chase lowering their target from $165 to $162, may indicate a cautious outlook on the stock's near-term performance. The stock has experienced fluctuations, with a 52-week high of $170.99 and a low of $137.62, suggesting potential volatility that could concern risk-averse investors. Insider ownership is relatively low at 0.20%, which may raise questions about the alignment of management's interests with those of shareholders. The company's debt-to-equity ratio of 0.44 indicates a moderate level of debt, which could be a concern if interest rates rise or if the company faces economic challenges. Procter & Gamble's recent performance has shown a slight decline, with stock trading down about 0.7%, which may deter investors looking for upward momentum. PG Forecast - Frequently Asked Questions What is Procter & Gamble's forecast for 2026? According to the research reports of 20 Wall Street equities research analysts, the average twelve-month stock price forecast for Procter & Gamble is $161.06, with a high forecast of $175.00 and a low forecast of $145.00. Should I buy or sell Procter & Gamble stock right now? 20 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Procter & Gamble in the last twelve months. There are currently 9 hold ratings and 11 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" PG shares. Does Procter & Gamble's stock price have much upside? According to analysts, Procter & Gamble's stock has a predicted upside of 11.46% based on their 12-month stock forecasts. Has Procter & Gamble been downgraded by Wall Street analysts recently? Over the previous 90 days, Procter & Gamble's stock had 1 downgrade by analysts. What analysts cover Procter & Gamble? Procter & Gamble has been rated by research analysts at Bank of America, Barclays, BNP Paribas Exane, Deutsche Bank Aktiengesellschaft, Erste Group Bank, Evercore, Jefferies Financial Group, JPMorgan Chase & Co., Morgan Stanley, Piper Sandler, Raymond James Financial, Rothschild & Co Redburn, Royal Bank Of Canada, TD Cowen, The Goldman Sachs Group, UBS Group, Weiss Ratings, and Wells Fargo & Company in the past 90 days. Do Wall Street analysts like Procter & Gamble more than its competitors? Analysts like Procter & Gamble more than other "consumer staples" companies. The consensus rating for Procter & Gamble is Moderate Buy while the average consensus rating for "consumer staples" companies is Hold. Learn more on how PG compares to other companies. Stock Forecasts and Research Tools Related Companies Costco Wholesale Stock Forecast Kimberly-Clark Stock Forecast PepsiCo Stock Forecast Tesla Stock Forecast Walmart Stock Forecast Church & Dwight Stock Forecast Colgate-Palmolive Stock Forecast Clorox Stock Forecast Johnson & Johnson Stock Forecast CocaCola Stock Forecast Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Brokerages With Procter & Gamble RecommendationsUBS GroupWells Fargo & CompanyTD CowenDeutsche Bank AktiengesellschaftEvercoreRothschild & Co RedburnPiper SandlerBNP Paribas ExaneMorgan StanleyJefferies Financial GroupJPMorgan Chase & Co.BarclaysRaymond James FinancialBank of AmericaRoyal Bank Of Canada This page (NYSE:PG) was last updated on 5/23/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredThe AI stocks about to become worthless (and one that isn't)Louis Navellier - who manages $1.1 billion including $358 million in AI stocks - says a new AI computer being ...InvestorPlace | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Procter & Gamble Company (The) Please log in to your account or sign up in order to add this asset to your watchlist. Share Procter & Gamble With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.